...
【24h】

Modeling the action of factor VIIa in dilutional coagulopathy.

机译:模拟因子VIIa在稀释性凝血病中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Dilutional coagulopathy is observed in patients who have lost blood and had the blood volume replaced with components that do not have plasma procoagulants and anticoagulants. Since both procoagulant and anticoagulant mechanisms contribute to total thrombin generation, it is not clear whether the procoagulant or anticoagulant effects will dominate when both are decreased. Decreasing antithrombin levels leads to increasing thrombin generation in ex vivo models. However, in these same models decreasing prothrombin leads to decreasing thrombin generation. Previous studies can be extrapolated to suggest that the ratio of procoagulants and anticoagulants may be the critical component in determining thrombin generation. Limited clinical data suggest that factor VIIa has been useful in controlling intractable bleeding in some cases of dilutional coagulopathy. Preliminary data suggest that factor VIIa activation of factors X and IX on activated platelets enhances thrombin generation significantly in a model of dilutional coagulopathy. This may suggest a mechanism to account for the efficacy of factor VIIa in reducing blood loss in some settings of dilutional coagulopathy.
机译:在失血并用不含血浆促凝剂和抗凝剂的成分代替血容量的患者中观察到稀释性凝血病。由于促凝血和抗凝血机制均有助于总凝血酶的产生,因此尚不清楚当两者均降低时促凝血或抗凝血作用是否占主导。抗凝血酶水平的降低导致离体模型中凝血酶产生的增加。但是,在这些相同的模型中,凝血酶原减少会导致凝血酶生成减少。可以推断以前的研究结果,表明促凝剂和抗凝剂的比例可能是决定凝血酶产生的关键因素。有限的临床数据表明,在稀释性凝血病的某些情况下,VIIa因子可用于控制顽固性出血。初步数据表明,在稀释性凝血病模型中,凝血因子VIIa激活的血小板上的因子X和IX的激活显着增强了凝血酶的产生。这可能暗示了一种机制,可以解释在稀释性凝血病的某些情况下因子VIIa在减少失血中的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号